BioPharma Resources

Drug Trial Radar · NCT06235151

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

443

Actual

Start

Apr 1, 2024

Primary completion

Oct 30, 2026

Study completion Oct 30, 2026

Sponsor

Lead sponsor
Curium US LLCIndustry
Sponsor type
Industry
First posted
Jan 31, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate cancer.

Conditions

  • Prostate Cancer
  • Prostate Adenocarcinoma

Interventions

  • Copper Cu 64 PSMA I&TDrug

    Radiopharmaceutical PET imaging tracer injected intravenously for staging of prostate cancer.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SensitivityTime frame: 4 Hours
  2. SpecificityTime frame: 4 Hours

Locations

43 sites in 1 country. Site status is shown where the registry gives one.

  • Urology Centers of Alabama

    Homewood, Alabama

  • Arkansas Urology

    Little Rock, Arkansas

  • Providence Medical Foundation

    Fullerton, California

  • Tower Urology

    Los Angeles, California

  • VA Greater Los Angeles Healthcare System

    Los Angeles, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • University of California, Irvine

    Orange, California

  • San Francisco VA Medical Center

    San Francisco, California

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California

  • Providence Saint John's Health Center

    Santa Monica, California

  • Stanford Hospital & Clinics

    Stanford, California

  • Georgetown University Medical Center

    Washington D.C., District of Columbia

  • University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center

    Miami, Florida

  • CIRA Health

    Miami, Florida

  • Sarasota Memorial Health Care System

    Sarasota, Florida

  • Florida Urology Partners

    Tampa, Florida

  • Edward Hines Jr. VA Hospital

    Hines, Illinois

  • Urology of Indiana, LLC

    Carmel, Indiana

  • IU Health Neuroscience Center

    Indianapolis, Indiana

  • University of Iowa

    Iowa City, Iowa

  • The University of Kansas Hospital

    Kansas City, Kansas

  • United Theranostics

    Glen Burnie, Maryland

  • VA Boston Healthcare System

    Boston, Massachusetts

  • M Health Fairview University of Minnesota Medical Center

    Minneapolis, Minnesota

  • SSM Health Saint Louis University Hospital

    St Louis, Missouri

  • John Cochran VA Medical Center

    St Louis, Missouri

  • Great Plains Health, Diagnostic Imaging

    North Platte, Nebraska

  • XCancer

    Omaha, Nebraska

  • United Theranostics

    Princeton, New Jersey

  • Adaptive Research Inc.

    Hawthorne, New York

  • Columbia University Medical Center

    New York, New York

  • James J. Peters VA Medical Center

    The Bronx, New York

  • UNC Cancer Center

    Chapel Hill, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Dayton Physicians Network / Greater Dayton Cancer Center

    Kettering, Ohio

  • VA Portland Health Care System

    Portland, Oregon

  • Hollings Cancer Center

    Charleston, South Carolina

  • Carolina Urologic Research Center, LLC

    Myrtle Beach, South Carolina

  • University of Tennessee Medical Center

    Knoxville, Tennessee

  • Excel Diagnostics and Nuclear Oncology Center

    Houston, Texas

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.